SEC Tracker
Get the app

Zeo ScientifiX ZEOX

Zeo ScientifiX files 10-KT for 2026 transition period

Form
10-KT
Filed
Importance
Routine
  1. Fiscal year end changed from October 31 to June 30
  2. Launched two IRB-approved clinical studies
  3. Sold Exotropin interests on April 7, 2026
  4. Entered strategic partnership with Cytora and Made Scientific

Written from the 10-KT on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Zeo ScientifiX files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Sunshine Biopharma SBFM public float $7M, Jun 30, 2025
  2. Neuphoria Therapeutics NEUP public float $7M, Dec 31, 2025
  3. CV Sciences CVSI public float $7M, Jun 30, 2025
  4. Minerva Neurosciences NERV public float $7M, Jun 30, 2025
  5. Bolt Biotherapeutics BOLT public float $7M, Jun 30, 2025